Millennium Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.87M | Buy |
622,853
+473,882
| +318% | +$5.2M | ﹤0.01% | 2765 |
|
|
2025
Q4 | $1.85M | Sell |
148,971
-75,995
| -34% | -$1.01M | ﹤0.01% | 4011 |
|
|
2025
Q3 | $3.22M | Sell |
224,966
-611,848
| -73% | -$8.38M | ﹤0.01% | 3581 |
|
|
2025
Q2 | $10.3M | Buy |
836,814
+417,838
| +100% | +$6.07M | 0.01% | 2227 |
|
|
2025
Q1 | $9.21M | Buy |
418,976
+397,029
| +1,809% | +$9.34M | ﹤0.01% | 2273 |
|
|
2024
Q4 | $498K | Sell |
21,947
-169,856
| -89% | -$3.71M | ﹤0.01% | 4756 |
|
|
2024
Q3 | $3.49M | Buy |
191,803
+174,286
| +995% | +$4.04M | ﹤0.01% | 3175 |
|
|
2024
Q2 | $510K | Sell |
17,517
-275,838
| -94% | -$8.18M | ﹤0.01% | 4573 |
|
|
2024
Q1 | $10.4M | Sell |
293,355
-103,714
| -26% | -$4.15M | ﹤0.01% | 2154 |
|
|
2023
Q4 | $17.3M | Buy |
397,069
+231,172
| +139% | +$9.1M | 0.01% | 1664 |
|
|
2023
Q3 | $6.34M | Buy |
165,897
+38,756
| +30% | +$1.63M | ﹤0.01% | 2481 |
|
|
2023
Q2 | $5.23M | Buy |
127,141
+74,785
| +143% | +$3.6M | ﹤0.01% | 2639 |
|
|
2023
Q1 | $3.01M | Sell |
52,356
-480,619
| -90% | -$27.1M | ﹤0.01% | 3048 |
|
|
2022
Q4 | $29.9M | Buy |
532,975
+134,226
| +34% | +$6.83M | 0.02% | 1117 |
|
|
2022
Q3 | $16.9M | Sell |
398,749
-58,320
| -13% | -$2.99M | 0.01% | 1513 |
|
|
2022
Q2 | $24.7M | Buy |
457,069
+133,571
| +41% | +$8.02M | 0.02% | 1112 |
|
|
2022
Q1 | $20.8M | Buy |
323,498
+230,761
| +249% | +$15.2M | 0.01% | 1351 |
|
|
2021
Q4 | $6.21M | Buy |
+92,737
| New | +$6.27M | ﹤0.01% | 2670 |
|
|
2021
Q3 | – | Sell |
-10,074
| Closed | -$687K | – | 6988 |
|
|
2021
Q2 | $687K | Sell |
10,074
-202,275
| -95% | -$14.3M | ﹤0.01% | 5010 |
|
|
2021
Q1 | $14.7M | Buy |
+212,349
| New | +$14.4M | 0.01% | 1390 |
|
|
2020
Q4 | – | Sell |
-139,316
| Closed | -$7.5M | – | 5370 |
|
|
2020
Q3 | $6.58K | Sell |
139,316
-221,147
| -61% | -$10.5M | 0.01% | 1592 |
|
|
2020
Q2 | $16.9M | Sell |
360,463
-62,721
| -15% | -$3.08M | 0.02% | 841 |
|
|
2020
Q1 | $18.9M | Buy |
423,184
+413,343
| +4,200% | +$21.7M | 0.04% | 479 |
|
|
2019
Q4 | $574K | Sell |
9,841
-201,590
| -95% | -$12M | ﹤0.01% | 3303 |
|
|
2019
Q3 | $12.7M | Buy |
+211,431
| New | +$12.6M | 0.02% | 1110 |
|
|
2019
Q2 | – | Sell |
-340,238
| Closed | -$17.5M | – | 4216 |
|
|
2019
Q1 | $19M | Buy |
340,238
+73,141
| +27% | +$3.73M | 0.03% | 831 |
|
|
2018
Q4 | $12M | Sell |
267,097
-139,701
| -34% | -$7.66M | 0.02% | 1014 |
|
|
2018
Q3 | $26.8M | Sell |
406,798
-311,463
| -43% | -$19.4M | 0.03% | 686 |
|
|
2018
Q2 | $46.3M | Buy |
+718,261
| New | +$44.5M | 0.06% | 440 |
|
|
2018
Q1 | – | Sell |
-15,689
| Closed | -$751K | – | 3832 |
|
|
2017
Q4 | $751K | Buy |
+15,689
| New | +$768K | ﹤0.01% | 2878 |
|
|
2017
Q2 | – | Sell |
-1,406,778
| Closed | -$59.3M | – | 3623 |
|
|
2017
Q1 | $59.3M | Buy |
1,406,778
+760,876
| +118% | +$32.5M | 0.11% | 265 |
|
|
2016
Q4 | $27.7M | Buy |
645,902
+505,006
| +358% | +$20.5M | 0.06% | 466 |
|
|
2016
Q3 | $5.82M | Sell |
140,896
-29,118
| -17% | -$1.22M | 0.01% | 1245 |
|
|
2016
Q2 | $6.78M | Sell |
170,014
-429,668
| -72% | -$15.5M | 0.02% | 1067 |
|
|
2016
Q1 | $20.2M | Buy |
599,682
+144,502
| +32% | +$4.5M | 0.05% | 480 |
|
|
2015
Q4 | $15.4M | Buy |
455,180
+239,224
| +111% | +$7.48M | 0.03% | 680 |
|
|
2015
Q3 | $6.43M | Sell |
215,956
-242,280
| -53% | -$7.58M | 0.01% | 1192 |
|
|
2015
Q2 | $12.6M | Buy |
+458,236
| New | +$12.2M | 0.02% | 840 |
|
|
2013
Q4 | – | Sell |
-48,929
| Closed | -$805K | – | 3582 |
|
|
2013
Q3 | $805K | Buy |
+48,929
| New | +$785K | ﹤0.01% | 2256 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Millennium Management's IART Position: Q1 2026 in Review
Millennium Management increased its Integra LifeSciences (IART) stake by 318% in Q1 2026, buying an estimated $5.2M and bringing the position to 622,853 shares worth $5.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2765.
Millennium Management first reported a position in IART in Q3 2013 and has held it in 39 quarters since. The position peaked at $59.3M in Q1 2017. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Millennium Management held 622,853 shares of Integra LifeSciences worth $5.87M as of Q1 2026.
- Millennium Management bought 473,882 Integra LifeSciences shares in Q1 2026, an estimated $5.2M.
- Integra LifeSciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2765 holding.
- Millennium Management first reported a position in Integra LifeSciences in Q3 2013 and has held it in 39 quarters since.
- Millennium Management's Integra LifeSciences position peaked at $59.3M in Q1 2017.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.